Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


Six killed in Swiss bus blaze after person reportedly sets themselves on fire
US says it destroyed mine-laying vessels as Trump warns Iran over strait
Britain working with allies to support shipping through Strait of Hormuz
Wildlife to replace humans on next series of UK banknotes
Five Iranian women's soccer players granted humanitarian visas in Australia